First Canadian to receive procedure says she would do it ‘a million times over’ compared with previous work to keep blood ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and conferred improved outcomes and insulin independence at 1 year in a small study of ...

With respect to islet transplantation a further difficulty is that many of the current agents damage beta cells or induce peripheral insulin resistance. 4 To address this problem, we developed a ...

PHOTO: Marlaina Goedel was diagnosed with Type 1 diabetes at age 5 and recently underwent an islet cell transplant. ( Courtesy Marlaina Goedel via UChicago Medicine) Goedel said her diabetes ...

A stained graft which was retrieved six weeks after islet and reprogrammed vascular endothelial cell (R-VEC) ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

The first attempts to transplant islet cells to treat type 1 diabetes began half a century ago. Doctors then sought the pancreatic tissue of deceased donors from which islet-producing tissue was ...

I’m in shock. I’m going to need you to repeat that.’" Goedel, like Gilada, underwent an islet cell transplant through a clinical trial at the University of Chicago Medicine Transplant ...

In the United States, where islet-cell transplants are still considered experimental, Vertex Pharmaceuticals of South Boston, Massachusetts, is actively involved in U.S. research and clinical trials.